Neurofeedback to Treat Depression - 2
RecruitingNCT07159061Phase: NAStarted 2025-11-21
Summary
This study tests the efficacy of a new psychotherapeutic strategy for reducing negative attention bias (and therefore depression severity) in participants with MDD. This real-time fMRI neurofeedback t
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
65 Years
Locations
Center for Neuromodulation in Depression and StressPhiladelphia, Pennsylvania, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07159061